Home / Inspections / 1225765

FDA Inspection 1225765 — Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent

Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent — FEI 3004513862

The FDA completed an inspection of Women's Care Fertility & Reproductive Medicine, Atrium Health-Navicent on December 14, 2023 in Macon, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 14, 2023
Fiscal Year
2024
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Macon, GA (United States)

Facility

Other inspections at this facility

  • 1119686 (NAI Tue Jan 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019658 (NAI Mon Jun 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 940598 (NAI Wed Sep 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 874897 (NAI Thu Apr 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 770751 (NAI Mon Mar 05 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources